Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Portella

Showing results (841-850 of 950) with videos related to

Pageof 95
Sort By:
Journal of Medicinal Chemistry|August 30, 2016
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) AntagonistsSalvatore Di Maro, Anna Maria Trotta, Diego Brancaccio, et al.
Frontiers in Pharmacology|December 11, 2024
Charting the therapeutic landscape: a comprehensive evidence map on medical cannabis for health outcomesPatrícia Montagner, Adán de Salas Quiroga, Arthur Schveitzer Ferreira, et al.
Ciencia & Saude Coletiva|March 17, 2021
Reduction of inequities of access to appropriate childbirth care in Rede CegonhaMaria do Carmo Leal, Ana Paula Esteves-Pereira, Maria Esther de Albuquerque Vilela, et al.
Elife|April 14, 2017
The RNF168 paralog RNF169 defines a new class of ubiquitylated histone reader involved in the response to DNA damageJulianne Kitevski-LeBlanc, Amélie Fradet-Turcotte, Predrag Kukic, et al.
BMC Psychiatry|May 8, 2019
Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trialMuriel Vicent-Gil, Beatriz Raventós, Eduardo D Marín-Martínez, et al.
Cell Death & Disease|July 24, 2019
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cellsCaterina Ieranò, Crescenzo D'Alterio, Simona Giarra, et al.
Orphanet Journal of Rare Diseases|June 22, 2023
Estimated costs for Duchenne muscular dystrophy care in BrazilNayê Balzan Schneider, Erica Caetano Roos, Ana Lúcia Portella Staub, et al.
Journal of Medicinal Chemistry|March 4, 2021
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in TumorsAnna Maria Trotta, Michela Aurilio, Crescenzo D'Alterio, et al.
Brain Research|March 6, 2007
Long lasting sex-specific effects upon behavior and S100b levels after maternal separation and exposure to a model of post-traumatic stress disorder in ratsLuisa Amalia Diehl, Patrícia Pelufo Silveira, Marina C Leite, et al.
Critical Care Medicine|February 7, 2013
Sepsis-surviving mice are more susceptible to a secondary kidney insultViviane G Portella, João L Silva-Filho, Sharon S Landgraf, et al.
Pageof 95

Showing results (841-850 of 950) with videos related to

Sort By:
Pageof 95
Journal of Medicinal Chemistry|August 30, 2016
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) AntagonistsSalvatore Di Maro, Anna Maria Trotta, Diego Brancaccio, et al.
Frontiers in Pharmacology|December 11, 2024
Charting the therapeutic landscape: a comprehensive evidence map on medical cannabis for health outcomesPatrícia Montagner, Adán de Salas Quiroga, Arthur Schveitzer Ferreira, et al.
Ciencia & Saude Coletiva|March 17, 2021
Reduction of inequities of access to appropriate childbirth care in Rede CegonhaMaria do Carmo Leal, Ana Paula Esteves-Pereira, Maria Esther de Albuquerque Vilela, et al.
Elife|April 14, 2017
The RNF168 paralog RNF169 defines a new class of ubiquitylated histone reader involved in the response to DNA damageJulianne Kitevski-LeBlanc, Amélie Fradet-Turcotte, Predrag Kukic, et al.
BMC Psychiatry|May 8, 2019
Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trialMuriel Vicent-Gil, Beatriz Raventós, Eduardo D Marín-Martínez, et al.
Cell Death & Disease|July 24, 2019
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cellsCaterina Ieranò, Crescenzo D'Alterio, Simona Giarra, et al.
Orphanet Journal of Rare Diseases|June 22, 2023
Estimated costs for Duchenne muscular dystrophy care in BrazilNayê Balzan Schneider, Erica Caetano Roos, Ana Lúcia Portella Staub, et al.
Journal of Medicinal Chemistry|March 4, 2021
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in TumorsAnna Maria Trotta, Michela Aurilio, Crescenzo D'Alterio, et al.
Brain Research|March 6, 2007
Long lasting sex-specific effects upon behavior and S100b levels after maternal separation and exposure to a model of post-traumatic stress disorder in ratsLuisa Amalia Diehl, Patrícia Pelufo Silveira, Marina C Leite, et al.
Critical Care Medicine|February 7, 2013
Sepsis-surviving mice are more susceptible to a secondary kidney insultViviane G Portella, João L Silva-Filho, Sharon S Landgraf, et al.
Pageof 95